GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » Price-to-Free-Cash-Flow

Danaher (Danaher) Price-to-Free-Cash-Flow

: 30.38 (As of Today)
View and export this data going back to 1986. Start your Free Trial

As of today (2024-04-18), Danaher's share price is $236.36. Danaher's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.78. Hence, Danaher's Price-to-Free-Cash-Flow Ratio for today is 30.38.

The historical rank and industry rank for Danaher's Price-to-Free-Cash-Flow or its related term are showing as below:

DHR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.73   Med: 21.4   Max: 35.77
Current: 30.39

During the past 13 years, Danaher's highest Price-to-Free-Cash-Flow Ratio was 35.77. The lowest was 9.73. And the median was 21.40.

DHR's Price-to-Free-Cash-Flow is ranked worse than
58.24% of 91 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.2 vs DHR: 30.39

Danaher's Free Cash Flow per Share for the three months ended in Dec. 2023 was $1.63. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $7.78.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Danaher was -22.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 1.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 15.30% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.10% per year.

During the past 13 years, Danaher's highest 3-Year average Free Cash Flow per Share Growth Rate was 63.00% per year. The lowest was -3.60% per year. And the median was 17.20% per year.


Danaher Price-to-Free-Cash-Flow Historical Data

The historical data trend for Danaher's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.76 26.12 30.19 23.43 29.74

Danaher Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.43 22.39 21.73 23.92 29.74

Competitive Comparison

For the Diagnostics & Research subindustry, Danaher's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher Price-to-Free-Cash-Flow Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Danaher's Price-to-Free-Cash-Flow falls into.



Danaher Price-to-Free-Cash-Flow Calculation

Danaher's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=236.36/7.779
=30.38

Danaher's Share Price of today is $236.36.
Danaher's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Danaher  (NYSE:DHR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Danaher Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Danaher's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher (Danaher) Business Description

Address
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Executives
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003
Mitchell P Rales director, officer: Chairman of Exec. Committee 11790 GLEN ROAD, POTOMAC MD 20854
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037

Danaher (Danaher) Headlines

From GuruFocus

Q2 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024